Organization
Oyster Point Pharma
4 clinical trials
Clinical trial
Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study)-Long Term Safety Follow-upStatus: Completed, Estimated PCD: 2019-09-20
Clinical trial
A Phase 4, Single-Center, Open-Label Study Evaluating the Safety of the Tyrvaya Nasal PumpStatus: Terminated, Estimated PCD: 2024-02-28
Clinical trial
A Phase 2, Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray in Subjects With Neurotrophic Keratopathy (the Olympia Study)Status: Completed, Estimated PCD: 2023-01-27
Clinical trial
A Phase 4, Single Center, Open Label Study Evaluating the Safety of the Nasal Guide Utilized During Administration With TyrvayaStatus: Completed, Estimated PCD: 2023-08-18